Congress returns to a packed health care agenda You’re reading STAT’s D.C. Diagnosis newsletter By John WilkersonApril 14, 2026 Washington Correspondent

https://www.statnews.com/2026/04/14/congress-health-care-agenda-drug-prices-reconciliation-dc-diagnosis/

Medical schools must continue to teach students about structural barriers to care The Liaison Committee on Medical Education’s decision to drop a requirement to teach about equity is worrisome

https://www.statnews.com/2026/04/15/lcme-structural-competency-medical-schools-equity/ By Uché BlackstockApril 15, 2026 Blackstock is an emergency physician and founder and CEO of Advancing Health Equity.

Flawed study on the antidepressant Paxil came with a cautionary note — if you knew how to find it Handling of an expression of concern on a paper raises bigger questions about scientific journals

https://www.statnews.com/pharmalot/2026/04/15/paxil-adolescent-antidepressant-pivotal-study-expression-concern/ By Ed SilvermanApril 15, 2026 Pharmalot Columnist, Senior Writer

Hosting the ‘intellectual wrestling match’ between MAHA, public health ‘Why Should I Trust You?’ brings together people who view each other skeptically — or worse

https://www.statnews.com/2026/04/15/why-should-i-trust-you-podcast-interview/ By Torie BoschApril 15, 2026 Editor, First Opinion

FDA panel will meet to discuss allowing broader access to certain peptides The move comes after RFK Jr. said he wanted to make the drugs more accessible By Lizzy Lawrence and Sarah ToddApril 15, 2026

https://www.statnews.com/2026/04/15/peptides-fda-panel-to-discuss-broader-access-compounding/ By Lizzy Lawrence and Sarah ToddApril 15, 2026

AI could check millions of CT scans for heart risk. Who will pay for it? Screening algorithms could flag undetected risk — and unleash a flood of billable follow-up care

https://www.statnews.com/2026/04/15/coronary-artery-calcium-ai-opportunistic-screening-examined/ By Katie PalmerApril 15, 2026 Health Tech Correspondent

FDA Launches READI-Home Innovation Challenge: Opportunities—and Tensions—for Home-Use Device Developers By Jennifer D. Newberger —

FDA Launches READI-Home Innovation Challenge: Opportunities—and Tensions—for Home-Use Device Developers By Jennifer D. Newberger — https://www.thefdalawblog.com/2026/04/fda-launches-readi-home-innovation-challenge-opportunities-and-tensions-for-home-use-device-developers/?utm_source=rss&utm_medium=rss&utm_campaign=fda-launches-readi-home-innovation-challenge-opportunities-and-tensions-for-home-use-device-developers On April 7, 2026, FDA’s Center for Devices and Radiological Health (CDRH) announced the READI-Home Innovation Challenge: Reducing Readmissions through Device Innovation for the Home, part of its broader Home as a Health Care Hub initiative. The program is intended to accelerate patient access to medical devices that support post-discharge care and reduce hospital readmissions.